Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly ...

CK Wang, MD, chief medical officer of COTA, discusses how real-world data help identify disparities and gaps in cancer care.

Good morning. You’ve got barely two more days to nominate a promising young researcher for this year’s STAT Wunderkinds.

Glenmark shares on Monday ended 0.68% up at ₹1,600.85 apiece on BSE. New Delhi: Glenmark Pharmaceuticals on Monday said it will launch cancer treatment drug zanubrutinib in India following ...

ADCs could account for $31 billion of the $375 billion worldwide cancer market in 2028, according to estimates from the drug market research firm Evaluate. ADCs still pose major challenges.

“Of all the things we have done, this one has the most impact on clinical practice over the long run,” said Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and ...